Product image
InVivoMAb anti-LCMV nucleoprotein
BE0106
ApplicationsFlow Cytometry, ImmunoFluorescence
Product group Antibodies
ReactivityVirus
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-LCMV nucleoprotein
- Delivery Days Customer7
- ApplicationsFlow Cytometry, ImmunoFluorescence
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDVL-4
- Concentration4-11 mg/ml
- HostRat
- IsotypeIgG2a
- Scientific DescriptionThe VL-4 antibody reacts with lymphocytic choriomeningitis virus (LCMV) nucleoprotein (NP), a 63 kDa structural protein. This antibody was generated by fusion of spleen cells of an LCMV strain WE immunized F1 rat with the YM3 myeloma cell line. This antibody has been shown to stain LCMV-infected cell internally with no surface staining. This antibody does not react with vaccinia, vesicular stomatitis or influenza virus-infected cells in the case of internal or surface staining.
- ReactivityVirus
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells. Herz J et al., 2015 Jul 27, J Exp MedRead more
- Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection. Ng CT et al., 2015 May 13, Cell Host MicrobeRead more
- A ceramide analogue stimulates dendritic cells to promote T cell responses upon virus infections. Pritzl CJ et al., 2015 May 1, J ImmunolRead more
- Early virus-host interactions dictate the course of a persistent infection. Sullivan BM et al., 2015 Jan, PLoS PathogRead more
- Lymphocytic choriomeningitis virus persistence promotes effector-like memory differentiation and enhances mucosal T cell distribution. Beura LK et al., 2015 Feb, J Leukoc BiolRead more
- Sphingosine analog AAL-R promotes activation of LCMV-infected dendritic cells. Seo YJ et al., 2014 Mar, Viral ImmunolRead more
- Type I interferon programs innate myeloid dynamics and gene expression in the virally infected nervous system. Nayak D et al., 2013, PLoS PathogRead more